Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a questionnaire conducted in Switzerland, Austria, and Belgium
暂无分享,去创建一个
A. Rüfer | K. Samii | A. Rovó | N. Cantoni | R. Benz | Sandra Ivic | G. Koenen | Davide Cavanna